Formulations of 14-epi-analogues of vitamin d and cmc

• 收藏
• 分享

专利权人:

HYBRIGENICS SA

发明人:

DELANSORNE RÉMI

申请号：

NZ60667911

公开号：

NZ606679A

申请日:

2011.07.13

申请国别(地区):

NZ

年份:

2014

代理人:

摘要：

The present disclosure provides formulations of a 14-epi-analogues of vitamin D, being inecalcitol (19-nor-9,10-seco-14bHcholesta-, 5(Z),7(E)-dien-23-ino-1a,3b,25-triol-23-yne), with carboxymethylcellulose, providing improved absorption profile. the formulations show an improved absorption of inecalcitol over the formulation in medium chain triglyceride. The formulation is useful for the prevention and/or treatment of rickets, osteoporosis, osteomalacia, psoriasis, autoimmune diseases such as multiple sclerosis or type I diabetes, hyperparathyroidism, benign prostate hyperplasia, any type of cancer or any vitamin D associated disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/